We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.77B
1-Year Est. Return 38.11%
This Fund
S&P 500
This Quarter Est. Return
-1.13%
1 Year Est. Return
+38.11%
3 Year Est. Return
+83.35%
5 Year Est. Return
+109.01%
10 Year Est. Return
+317.99%
AUM
$6.91B
AUM Growth
-$595M
Cap. Flow
-$467M
Cap. Flow %
-6.76%
Top 10 Hldgs %
35.1%
Holding
109
New
3
Increased
13
Reduced
72
Closed
4

Top Buys

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$33M
2
MAC icon
Macerich
MAC
+$13.1M
3
MAXR
Maxar Technologies Inc. Common Stock
MAXR
+$11.4M
4
SAVE
Spirit Airlines, Inc.
SAVE
+$6.66M
5
SPR
Spirit AeroSystems
SPR
+$6.66M

Top Sells

Rank Stock Value
1
ADNT icon
Adient
ADNT
+$77.2M
2
CNQ icon
Canadian Natural Resources
CNQ
+$36.3M
3
DKS icon
Dick's Sporting Goods
DKS
+$30.9M
4
CVE icon
Cenovus Energy
CVE
+$27.6M
5
TU icon
Telus
TU
+$27.4M

Sector Composition

Rank Sector Weight
1 Financials 28.74%
2 Energy 17.27%
3 Communication Services 15.86%
4 Materials 12.6%
5 Healthcare 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BAP icon
76
Credicorp
BAP
$29.9B
$12.4M 0.18%
112,025
+12,000
+12% +$1.31M
PROF
77
Profound Medical
PROF
$218M
$11.9M 0.17%
817,975
+6,900
+0.9% +$105K
CVE.WS
78
DELISTED
Cenovus Energy Inc Warrants
CVE.WS
$10.2M 0.15%
1,725,729
-38,989
-2% -$189K
FTS icon
79
Fortis
FTS
$27.6B
$7.58M 0.11%
170,775
+28,650
+20% +$1.3M
GT icon
80
Goodyear
GT
$1.53B
$7.37M 0.11%
416,608
-72,200
-15% -$1.17M
PDS
81
Precision Drilling
PDS
$1.11B
$6.01M 0.09%
148,605
-2,572
-2% -$88.6K
FLR icon
82
Fluor
FLR
$7.16B
$5.42M 0.08%
339,194
-39,475
-10% -$648K
YTRA icon
83
Yatra Online
YTRA
$72.3M
$4.32M 0.06%
2,138,020
– –
SCHW
84
Charles Schwab
SCHW
$186B
$1.59M 0.02%
21,846
– –
VT icon
85
Vanguard Total World Stock ETF
VT
$81B
$1.48M 0.02%
14,500
-3,700
-20% -$388K
ING icon
86
ING
ING
$105B
$1.45M 0.02%
99,700
-6,575
-6% -$87.9K
MYOV
87
DELISTED
Myovant Sciences Ltd.
MYOV
$1.42M 0.02%
63,204
– –
SPRO icon
88
Spero Therapeutics
SPRO
$65.8M
$1.36M 0.02%
73,659
– –
OM icon
89
Outset Medical
OM
$60.3M
$1.11M 0.02%
1,500
– –
MET icon
90
MetLife
MET
$61.7B
$809K 0.01%
13,099
– –
REPL icon
91
Replimune Group
REPL
$1.24B
$676K 0.01%
22,800
– –
HRTX icon
92
Heron Therapeutics
HRTX
$59.9M
$611K 0.01%
57,200
– –
QNCX icon
93
Quince Therapeutics
QNCX
$30.1M
$502K 0.01%
27
-20
-43% -$318K
ENB icon
94
Enbridge
ENB
$105B
$345K 0.01%
8,650
+1,675
+24% +$66.1K
BABA icon
95
Alibaba
BABA
$272B
$311K ﹤0.01%
+2,100
New +$382K
DUK icon
96
Duke Energy
DUK
$92.8B
$303K ﹤0.01%
3,100
– –
NUE icon
97
Nucor
NUE
$58.9B
$286K ﹤0.01%
2,900
– –
AAPL icon
98
Apple
AAPL
$4.86T
$283K ﹤0.01%
2,000
– –
IMV
99
DELISTED
IMV Inc. Common Shares
IMV
$279K ﹤0.01%
17,000
– –
MDNA
100
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$277K ﹤0.01%
+100,000
New +$248K
1 2 3
4
5

Similar funds

JWBC
John W. Bristol & Co New York $6.76B AUM 18.39% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
LIP
Liontrust Investment Partners London, United Kingdom $6.8B AUM 23.31% 1-Year Est. Return

Letko, Brosseau & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Letko, Brosseau & Associates held 109 positions worth $6.91B, down 7.9% from $7.5B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Letko, Brosseau & Associates withdrew a net $467M in Q3 2021, closing 4 positions and reducing 72 holdings. Its most notable exit was Adient, an estimated $77.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 28% a quarter earlier, followed by Energy and Communication Services.

Against the trend, Letko, Brosseau & Associates opened a new position in Bausch Health worth $32.5M.

  • Letko, Brosseau & Associates's largest Q3 2021 buy was Bausch Health: 1,164,200 shares worth $32.5M.
  • Letko, Brosseau & Associates added most to Macerich in Q3 2021, an estimated $13.1M increase.
  • Letko, Brosseau & Associates's biggest Q3 2021 reduction was Canadian Natural Resources, cutting an estimated $36.3M.
  • Letko, Brosseau & Associates fully exited Adient in Q3 2021, selling an estimated $77.2M.
  • Letko, Brosseau & Associates's ten largest holdings make up 35% of its $6.91B portfolio in Q3 2021.
  • Letko, Brosseau & Associates opened 3 new positions and closed 4 in Q3 2021.
  • Letko, Brosseau & Associates's portfolio value fell 7.9% quarter-over-quarter to $6.91B.

Based on Letko, Brosseau & Associates's 13F filing for Q3 2021, filed 3 Nov 2021.